Nucleus Drugs Private Limited
About Nucleus Drugs Private Limited
Data last updated:
Nucleus Drugs Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 21 December 2005.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2005PTC048507.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Gorla Srinivasa Reddy and Dodda Sridhar Kumar.
Its last annual general meeting (AGM) was held on 26 September 2008, and its latest financial statements are for the year ended 31 March 2008. The registered office was at Sh No: 337 Padmavathi Plaza Kphb Colony, Hyderabad, Telangana, India – 500072.
Court records list 1 case involving the company, including 1 filed against it.
Company details
CIN history
Nucleus Drugs has one previous CIN (Corporate Identification Number): U24230AP2005PTC048507. The current CIN is U24230TG2005PTC048507, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2005PTC048507 | Current |
| U24230AP2005PTC048507 | Previous |
Contact details
Nucleus Drugs Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressSh No: 337 Padmavathi Plaza Kphb Colony, Hyderabad, Telangana, India – 500072
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nucleus Drugs Private Limited
FY 2008 filings availableFinancial Statement Summary
| Metrics | FY 2007-08 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2007-08 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nucleus Drugs Private Limited, buy the company report.
Board of directors of Nucleus Drugs Private Limited
Nucleus Drugs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gorla Srinivasa Reddy | Director | 21 Dec 2005 | 20 Years 10 Months | As last reported |
| Dodda Sridhar Kumar Also directs: Glaxco Pharmaceuticals Private Limited | Director | 21 Dec 2005 | 20 Years 10 Months | As last reported |
Legal cases
Nucleus Drugs Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed against the company | Disposed |
To see the full case history of Nucleus Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nucleus Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nucleus Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nucleus Drugs Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Dodda Sridhar Kumar was appointed as Director on 21 Dec 2005.
Frequently asked questions
Nucleus Drugs has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Nucleus Drugs was a private limited company based in Hyderabad, Telangana, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 21 December 2005 and is registered under CIN U24230TG2005PTC048507. The company has been struck off by the Registrar of Companies and is no longer operational.
Nucleus Drugs had 2 directors:
- Gorla Srinivasa Reddy - Director
- Dodda Sridhar Kumar - Director
The CIN (Corporate Identification Number) of Nucleus Drugs is U24230TG2005PTC048507. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Nucleus Drugs is at Sh No: 337 Padmavathi Plaza Kphb Colony, Hyderabad, Telangana, India – 500072.
Nucleus Drugs was incorporated on 21 December 2005. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Nucleus Drugs on record with the MCA are for the year ended 31 March 2008. Its last annual general meeting was held on 26 September 2008. Year-wise statements from 2015 are in the company report.
Nucleus Drugs operated in the chemicals industry, in the other chemical product segment. It worked in this industry before it was struck off.
Nucleus Drugs has 1 court case on record: 1 filed against it.
Dodda Sridhar Kumar was appointed as Director on 21 Dec 2005. Gorla Srinivasa Reddy was appointed as Director on 21 Dec 2005.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
